Overview

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The goal of the pilot study is to determine if a multicenter prospective cohort study of cancer patients with blood clots associated with catheters is feasible. Cancer patients with catheter-related thrombosis treated with one month of anticoagulation will be evaluated for for post-thrombotic syndrome. Laboratory biomarkers will be evaluated as predictors of recurrent thrombosis.
Phase:
N/A
Details
Lead Sponsor:
Medical College of Wisconsin
Collaborators:
Blood Center of Wisconsin
Ohio State University
University of Minnesota - Clinical and Translational Science Institute
Versiti
Treatments:
Anticoagulants
Apixaban
Calcium heparin
Dabigatran
Dalteparin
Edoxaban
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight
Rivaroxaban
Tinzaparin